SCHEMBL9945693

SCHEMBL9945693

CCC[C@H](O)CF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9946205 1.00
SCHEMBL27298551 0.82
SCHEMBL8773006 0.80
Hexan-3-Ol SCHEMBL15033 0.80
Hexan-3-Ol SCHEMBL1462441 0.80
Hexan-3-Ol SCHEMBL464395 0.80
Hexan-3-Ol SCHEMBL11796163 0.80 LMNA (0.43)
SCHEMBL10290649 0.80 ALDH1A1 (0.33)
SCHEMBL22249 0.79
SCHEMBL27454228 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149683-A1 SUBSTITUTED AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed
EP-1954668-B1 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-09-28 EP disclosed